-
England to launch rapid asymptomatic COVID-19 testing this week
pharmatimes
January 12, 2021
The UK’s Department of Health and Social Care (DHSC) has announced that community testing for COVID-19 will now be offered to people without symptoms in England, in a bid to protect people who are unable to work from home during the national lockdown.
-
Ampio Provides Update on Clinical Trials for COVID-19 Treatment
americanpharmaceuticalreview
January 12, 2021
Ampio Pharmaceuticals announced an update on the launch of a new global clinical trial for intravenous (IV) treatment of COVID-19 with Ampion and provided updates on its ongoing U.S. trial for inhalation treatment of COVID-19.
-
University of Calgary Joins Trial of LSALT Peptide for Complications in Hospitalized COVID-19 Patients
americanpharmaceuticalreview
January 12, 2021
Arch Biopartners announced the University of Calgary Cumming School of Medicine has joined the Phase II trial of its lead drug LSALT peptide (Metablok), targeting the prevention of acute lung injury, acute kidney injury, and other complications ...
-
Algeria registers Russian Sputnik V vaccine against Covid-19
pharmaceutical-technology
January 12, 2021
The Russian Direct Investment Fund (RDIF) has announced the registration of Sputnik V vaccine against Covid-19 by the National Agency of Pharmaceutical Products of People’s Democratic Republic of Algeria.
-
British Columbia rejects Health Canada-approved antibody drug for Covid-19
pharmaceutical-technology
January 12, 2021
British Columbia (BC) has rejected a Health Canada-approved antibody drug, bamlanivimab, for treating Covid-19 citing very limited safety data.
-
Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production
contractpharma
January 12, 2021
?Fujifilm Diosynth Biotechnologies, and the Texas A&M University System Center for Innovation in Advanced Development & Manufacturing (CIADM), have begun production on two different COVID-19 vaccine candidates with support from the U.S. government to ...
-
Baxter, Novavax Ink Sterile Manufacturing Agreement
contractpharma
January 12, 2021
CMO Baxter will help increase commercial production and promote access to Novavax' Covid-19 vax in UK and European markets.
-
Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients
prnasia
January 11, 2021
Kintor Pharmaceutical Limited is pleased to update the preliminary analysis of the clinical trial of Proxalutamide for the treatment of COVID-19 patients.
-
Value of pharma’s M&A deals remain high, despite COVID-19
europeanpharmaceuticalreview
January 11, 2021
Analysts say M&A deals continue to be a core driver of pharma/biopharma industry growth and that 2021 will likely be another year of high deal value.
-
Blue Note Therapeutics Partnering with Patient Advocacy Groups to Provide Digital Cancer-Related Mental Health Care During Pandemic
prnewswire
January 11, 2021
Nearly all cancer patients face fear, anxiety, and uncertainty following diagnosis and treatment. Cancer-related distress can impact a patient's emotional and physical well-being, which for many has been further compounded by the COVID-19 pandemic.